TCL Archive Senate Votes To Kill A 10% Cut For NIH; Less Severe Budget Cuts Still Possible May 26, 1995
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Also in this 12-page issue: ASCO urges freeze of Medicare payments for chemotherapy at 2004 levels for next two years. February 20, 2004
